Back to Trades
Other4
Kiniksa Pharmaceuticals International, plc
KNSA
Total Value
$0
Company Information
- Company Name
- Kiniksa Pharmaceuticals International, plc
- Ticker Symbol
- KNSA
- CIK
- 0001730430
Insider Information
- Name
- Levy Richard S
- Role
- Insider
- Location
- LONDON, X0
Filing Details
- Filing Date
- Feb 4, 2026
- Transaction Date
- Feb 1, 2026
- Accession Number
- 0001454983-26-000002
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Feb 1, 2026 | Class A Ordinary Share | 683 | — | Exercise | — |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Feb 1, 2026 | Derivative | 683 | — | Grant/Award | — |
| Feb 1, 2026 | Derivative | 683 | — | Exercise | — |
Footnotes
- (F1)Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.
- (F2)The RSUs vested immediately upon grant on February 1, 2026; there was no expiration date for the RSUs.